CN111793038A - Environment-friendly preparation method of substituted oxazole compound - Google Patents

Environment-friendly preparation method of substituted oxazole compound Download PDF

Info

Publication number
CN111793038A
CN111793038A CN201910276111.8A CN201910276111A CN111793038A CN 111793038 A CN111793038 A CN 111793038A CN 201910276111 A CN201910276111 A CN 201910276111A CN 111793038 A CN111793038 A CN 111793038A
Authority
CN
China
Prior art keywords
formula
compound
aryl phosphine
substituted
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910276111.8A
Other languages
Chinese (zh)
Other versions
CN111793038B (en
Inventor
周立山
王成威
刘宁宁
戚聿新
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xinfa Pharmaceutical Co Ltd
Original Assignee
Xinfa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xinfa Pharmaceutical Co Ltd filed Critical Xinfa Pharmaceutical Co Ltd
Priority to CN201910276111.8A priority Critical patent/CN111793038B/en
Publication of CN111793038A publication Critical patent/CN111793038A/en
Application granted granted Critical
Publication of CN111793038B publication Critical patent/CN111793038B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36One oxygen atom
    • C07D263/42One oxygen atom attached in position 5
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/10Process efficiency

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

The invention provides an environment-friendly preparation method of a substituted oxazole compound, which comprises the steps of taking N-substituted formyl-alpha-substituted glycine ester as a starting raw material, and carrying out cyclization reaction under the action of a dehydrating agent (a combination of trisubstituted aryl phosphine dichloride, trisubstituted aryl phosphine dichloride and an acyl chloride reagent or a combination of trisubstituted aryl phosphine oxide and an acyl chloride reagent) and organic amine to obtain the substituted oxazole compound. The obtained substituted oxazole compound can be further saponified and decarboxylated to obtain a medical intermediate 4-substituent-5-substituent oxyoxazole. The by-product trisubstituted aryl phosphine oxide in the reaction process can be recycled, so that the cost is reduced; the method does not use phosphorus oxychloride and phosphorus pentoxide dehydrating agents which are high in price and large in preparation process wastewater quantity, does not need high-temperature cyclization reaction, and is simple in process, simple and convenient to operate, free of phosphorus-containing wastewater discharge in the process, green, environment-friendly and low in cost; high atom economy, high yield and purity of target products and suitability for industrial application.

Description

Environment-friendly preparation method of substituted oxazole compound
Technical Field
The invention relates to an environment-friendly preparation method of a substituted oxazole compound, belonging to the technical field of pharmaceutical biochemical industry.
Background
Oxazole compounds are important intermediates for preparing substances with life activity, for example, 4-methyl-5-alkoxy oxazole is an important intermediate for synthesizing vitamin B6. Vitamin B6 is one of essential vitamins and plays a key role in the growth process of animals and human bodies, so that the vitamin B6 is widely applied to the fields of medicines, foods, feed additives, cosmetics industry and the like.
At present, the preparation of oxazole compound 4-methyl-5-alkoxy oxazole (taking 4-methyl-5-ethoxy oxazole as an example) mainly comprises the following two methods:
1. formyl cyclisation process
The literature "J.Am.chem.Soc.2007, 129, 4440-4455" and the literature "European Journal of medicinal Chemistry 62(2013) 486-487" are obtained by preparing ethyl N-formyl-2-aminopropionate through formylation by using ethyl 2-aminopropionate and then performing cyclization through the action of phosphorus pentoxide or other dehydrating agents. The preparation method consumes a large amount of phosphorus pentoxide through cyclization, has large wastewater amount, low yield and high cost, and is not beneficial to industrial amplification.
2. Oxalyl compound cyclization method
Chinese patent documents CN86101512A, CN102321043A and CN103435568A and the document 'Chinese medicine industry journal 2009,40(2)81-82, 96' take oxalyl as raw material, and prepare corresponding oxazole compound through cyclization; the preparation method specifically comprises the steps of taking L-alanine, excessive oxalic acid, ethanol and benzene as raw materials, refluxing and carrying water to prepare N-ethoxy oxalyl-L-alanine ethyl ester, cyclizing by phosphorus oxychloride-organic alkali to obtain an oxazole compound, and hydrolyzing and decarboxylating to prepare the 4-methyl-5-ethoxy oxazole. The method has the advantages of complex preparation process, high energy consumption, large amount of wastewater, high content of waste salt, poor atom economy, no contribution to environmental protection and high product cost, and needs to use a dehydrating agent such as phosphorus oxychloride for ring closure.
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides an environment-friendly preparation method of a substituted oxazole compound. According to the method, N-substituted formyl-alpha-substituted glycine ester is used as an initial raw material, easily-obtained tri-substituted aryl phosphine dichloride, a combination of tri-substituted aryl phosphine dichloride and an acyl chloride reagent or a combination of tri-substituted aryl phosphine oxide and an acyl chloride reagent is used as a dehydrating agent to prepare the substituted oxazole compound, and the by-product tri-substituted aryl phosphine oxide can be recycled, so that the cost is reduced. The method does not use phosphorus oxychloride and phosphorus pentoxide dehydrating agents which are high in price and large in preparation process wastewater quantity, does not need high-temperature cyclization reaction, and is simple in process, simple and convenient to operate, free of phosphorus-containing wastewater discharge in the process, green, environment-friendly and low in cost; high atom economy, high yield and purity of target products and suitability for industrial application.
Description of terms:
a compound of formula I: substituted oxazole compounds, i.e. 4-R2substituent-5-R1Substituent oxy-2-R3A substituent oxazole;
a compound of formula II: N-R3Substituent formyl-alpha-R2A substituent glycine ester;
a compound of formula III: 4-R2substituent-5-R1Substituent oxyoxazole-2-carboxylate;
a compound of formula IV: 4-R2substituent-5-R1A substituent oxyoxazole.
The compound numbers in the specification are completely consistent with the structural formula numbers, have the same reference relationship, and are based on the structural formula of the compound.
The technical scheme of the invention is as follows:
an environment-friendly preparation method of a substituted oxazole compound, comprising the steps of:
in a solvent A, under the action of a dehydrating agent and organic amine, a compound shown in a formula II is subjected to cyclization reaction to prepare a substituted oxazole compound (I); the dehydrating agent is a combination of trisubstituted aryl phosphine dichloride, trisubstituted aryl phosphine dichloride and acyl chloride reagent or a combination of trisubstituted aryl phosphine oxide and acyl chloride reagent;
Figure BDA0002020067300000021
wherein in the structural formula of the compound of the formula II, R1Is hydrogen, CnH2n+1A group (1 ≦ n ≦ 10), an aromatic group, or a substituted aromatic group; r2Is hydrogen, CnH2n+1A group (1 ≦ n ≦ 10), an aromatic group, or a substituted aromatic group; r3is-COOR, -CH2COOR or-CH2CH2COOR, wherein R is alkyl.
Preferably, the solvent A is one or a combination of dichloromethane, chloroform, n-hexane, cyclohexane, petroleum ether, n-heptane, xylene, chlorobenzene, benzene, toluene, dimethyl sulfoxide, trichloromethane, trichloroethane or dichloroethane; the mass ratio of the solvent A to the compound shown in the formula II is (0.5-12.0) to 1; preferably, the mass ratio of the solvent A to the compound of the formula II is (3.0-10.0): 1.
According to the invention, when the dehydrating agent is the combination of the tri-substituted aryl phosphine oxide and the acyl chloride reagent, the tri-substituted aryl phosphine oxide and the acyl chloride reagent can generate the tri-substituted aryl phosphine dichloride in situ, and then the dehydrating agent further plays a role in dehydration.
According to the invention, the tri-substituted aryl phosphine oxide is preferably of the formula Ar3PO, wherein Ar has a structure shown as formula V below; the structural formula of the tri-substituted aryl phosphine dichloride is Ar3PCl2Wherein Ar has a structure represented by formula V below;
Figure BDA0002020067300000022
wherein in the structural formula shown in the formula V, m is 1, 2, 3, 4 or 5, R4Is hydrogen, CnH2n+1A group (1 ≦ n ≦ 10) or chloro; preferably, R4Is hydrogen. The structural formula shown in formula V represents: with m radicals R4Respectively arbitrarily connected with six carbon atoms of a benzene ring.
Preferably, the trisubstituted aryl phosphine oxide is triarylphosphine oxide or tris (4-methylphenyl) phosphine oxide and the trisubstituted aryl phosphine dichloride is triarylphosphine dichloride.
Preferably, according to the invention, when the dehydrating agent is a trisubstituted aryl phosphine dichloride, the molar ratio of the trisubstituted aryl phosphine dichloride to the compound of formula II is (0.01-5.0): 1; preferably, the molar ratio of the trisubstituted aryl phosphine dichloride to the compound of formula II is (0.1-1.5): 1; when the dehydrating agent is the combination of the tri-substituted aryl phosphine oxide and the acyl chloride reagent, the molar ratio of the acyl chloride reagent to the compound shown in the formula II is (0.1-2.0):1, and the molar ratio of the tri-substituted aryl phosphine oxide to the compound shown in the formula II is (0.01-5.0): 1; preferably, the molar ratio of the acid chloride reagent to the compound of formula II is (0.3-1):1, and the molar ratio of the trisubstituted aryl phosphine oxide to the compound of formula II is (0.1-1.5): 1; when the dehydrating agent is the combination of the tri-substituted aryl phosphine dichloride and the acyl chloride reagent, the molar ratio of the acyl chloride reagent to the compound shown in the formula II is (0.1-2.0):1, and the molar ratio of the tri-substituted aryl phosphine dichloride to the compound shown in the formula II is (0.01-5.0): 1; preferably, the molar ratio of the acid chloride reagent to the compound of formula II is (0.3-1):1, and the molar ratio of the trisubstituted aryl phosphine dichloride to the compound of formula II is (0.1-1.5): 1.
Preferably, according to the invention, the acid chloride reagent is sulfuryl chloride, thionyl chloride, oxalyl chloride, carbonyl chloride, phosgene, diphosgene or triphosgene; preferably phosgene or triphosgene.
Preferably, according to the invention, the acid chloride reagent is added to the system in a dropwise manner.
According to a preferred embodiment of the invention, the organic amine is a trialkylamine and the alkyl group has the general formula CnH2n+1(1 ≦ n ≦ 10); preferably, the alkyl group is a methyl group, an ethyl group, an isopropyl group, an n-propyl group, an isobutyl group or an n-butyl group, and more preferably an ethyl group, an n-propyl group or an n-butyl group; the molar ratio of the organic amine to the compound of the formula II is (1.8-4.0) to 1; preferably, the molar ratio of the organic amine to the compound of the formula II is (2.0-3.0): 1.
According to the invention, the compound of the formula II is preferably one or the combination of more than two of N-ethoxy oxalyl glycine ethyl ester, N-ethoxy oxalyl-alpha-alanine ethyl ester, N-ethoxy oxalyl glycine methyl ester, N-methoxy oxalyl-alpha-alanine methyl ester, N-ethoxy oxalyl-alpha-phenyl glycine ethyl ester or N-ethoxy oxalyl-alpha-alanine methyl ester.
Preferably, according to the invention, the cyclization reaction temperature is 10-80 ℃; preferably, the cyclization reaction temperature is 30-75 ℃. The cyclization reaction time is 0.5-10 hours.
According to the invention, the compound of formula II is preferably subjected to cyclization reaction to obtain a reaction solution, and the post-treatment method of the obtained reaction solution comprises the following steps: adding water into the obtained reaction liquid, layering, extracting the obtained water layer by using a solvent A, and combining organic phases to obtain a water phase and an organic phase; distilling the organic phase at normal pressure to recover the solvent A, and then distilling the organic phase at reduced pressure to obtain a substituted oxazole compound (I); the obtained water phase or the residue of reduced pressure distillation contains trisubstituted aryl phosphine oxide, and the trisubstituted aryl phosphine oxide can be prepared by reacting with acyl chloride reagent to be used as a dehydrating agent or directly recycled to be used as the dehydrating agent; the obtained water phase can be neutralized by sodium hydroxide and distilled to recover organic amine.
According to the method, organic amine is used as an acid-binding agent to generate organic amine hydrochloride with byproduct hydrogen chloride in the reaction process, then sodium hydroxide and the organic amine hydrochloride are used for neutralization, and finally, the organic amine is recovered and the byproduct sodium chloride is produced.
According to the invention, the substituted oxazole compound (I) can be further prepared into the following oxazole medical intermediate compound formula IV according to the prior art.
According to the invention, the substituted oxazole compound (I) can be used for preparing the compound shown in the formula III through saponification reaction under the action of alkali; then preparing a compound shown in the formula IV by decarboxylation reaction under an acidic condition;
Figure BDA0002020067300000041
wherein, in the structural formula of the compound shown in the formula III, a substituent R1、R2And a substituent R in the structural formula of a compound shown in a formula II1、R2Similarly, M is an alkali metal and x is 0, 1 or 2, wherein x is 0 meaning that COOM is directly attached to the oxazole ring; in the structural formula of the compound shown in the formula IV, a substituent R1、R2And a substituent R in the structural formula of a compound shown in a formula II1、R2The same is true.
According to the invention, the saponification, the base used and the decarboxylation can be carried out according to the known art.
Preferably, the alkali is an alkali metal hydroxide aqueous solution with the mass concentration of 20-30%; the alkali metal is preferably sodium or potassium; the molar ratio of the alkali to the substituted oxazole compound (I) is 1-1.5: 1; the saponification reaction temperature is 20-30 ℃. The saponification reaction time is 10-60 minutes.
Preferably, the acidic condition is that the pH value of the system is adjusted to be 1-2 by using an acid aqueous solution with the mass concentration of 20-35%; the decarboxylation reaction temperature is 50-70 ℃. The decarboxylation reaction time is 10-60 minutes.
Preferably, the preparation of the compound of formula iv comprises the steps of: performing cyclization reaction on a compound of a formula II to obtain a reaction solution, adding water into the obtained reaction solution, layering, extracting an obtained water layer by using a solvent A, combining organic phases, and adding alkali into the organic phases to perform saponification reaction; and after the reaction is finished, layering, washing the obtained organic layer with water, combining water layers, adding an aqueous solution of acid into the obtained aqueous layer which is a solution containing the compound shown in the formula III, and performing deacidification reaction to obtain the compound shown in the formula IV. After the compound shown in the formula IV is separated, the residual water phase or organic phase contains the trisubstituted aryl phosphine oxide, and the trisubstituted aryl phosphine dichloride prepared by the method and an acyl chloride reagent can be used as a dehydrating agent or directly recycled as the dehydrating agent.
The reaction route of the method is as follows:
Figure BDA0002020067300000042
wherein in the structural formula of the compound of the formula II, R1Is hydrogen, CnH2n+1A group (1 ≦ n ≦ 10), an aromatic group, or a substituted aromatic group; r2Is hydrogen, CnH2n+1A group (1 ≦ n ≦ 10), an aromatic group, or a substituted aromatic group; r3is-COOR, -CH2COOR or-CH2CH2COOR, wherein R is alkyl. R in the structural formula of the compound of formula I1、R2、R3R in the structural formula of the compound of the formula IV1、R2Are all consistent with the structural formula of the compound shown in the formula II.
The invention has the technical characteristics and beneficial effects that:
1. the invention provides a novel environment-friendly method for preparing a substituted oxazole compound by cyclization; taking N-substituted formyl-alpha-substituted glycine ester (II) as an initial raw material, and reacting a dehydrating agent and organic amine to obtain a substituted oxazole compound (I) by using a combination of trisubstituted aryl phosphine dichloride, trisubstituted aryl phosphine dichloride and an acyl chloride reagent or a combination of trisubstituted aryl phosphine oxide and an acyl chloride reagent as the dehydrating agent. The obtained substituted oxazole compound (I) can be prepared into 4-substituent-5-substituent oxyoxazole (IV) through saponification reaction and decarboxylation reaction according to the prior art.
2. The whole reaction process of the invention can be understood as follows: removing one molecule of water from the compound shown in the formula II through cyclization reaction, reacting the water with tri-substituted aryl phosphine dichloride to generate tri-substituted aryl phosphine oxide and two molecules of hydrogen chloride, and reacting the two molecules of hydrogen chloride with acid-binding agent organic amine to generate organic amine hydrochloride. The dehydrating agent used in the method is a combination of trisubstituted aryl phosphine dichloride, trisubstituted aryl phosphine dichloride and acyl chloride reagent or a combination of trisubstituted aryl phosphine oxide and acyl chloride reagent; when the dehydrating agent is the combination of the trisubstituted aryl phosphine dichloride and the acyl chloride reagent, the trisubstituted aryl phosphine dichloride after the dehydration reaction is converted into the trisubstituted aryl phosphine oxide, and the trisubstituted aryl phosphine oxide and the acyl chloride reagent react in situ to generate the trisubstituted aryl phosphine dichloride which can continuously participate in the dehydration reaction; when the dehydrating agent is the combination of the tri-substituted aryl phosphine oxide and the acyl chloride reagent, the acyl chloride reagent enables the tri-substituted aryl phosphine oxide to generate the tri-substituted aryl phosphine dichloride in situ, and then cyclization reaction is carried out, only sodium chloride and byproduct gas such as sulfur dioxide or carbon dioxide are generated in the process, the generation amount of waste water and waste gas is less, and the method is green and environment-friendly. The dehydrating agent is easy to prepare; the tri-substituted aryl phosphine oxide which is a byproduct in the reaction for preparing the substituted oxazole compound can be recycled, and can be easily and quantitatively converted into the tri-substituted aryl phosphine dichloride, so that the cost is reduced, the cyclic utilization of materials is realized, and the concepts of environmental protection and atom economy are met. The method does not use phosphorus oxychloride and phosphorus pentoxide dehydrating agents which are high in price and large in preparation process wastewater quantity, does not need high-temperature cyclization reaction, and is simple in process, simple and convenient to operate, free of phosphorus-containing wastewater discharge in the process, green, environment-friendly and low in cost.
3. The method has the advantages of high reaction activity, good reaction selectivity, high atom economy, high product yield and purity, high yield of more than 95 percent and high purity of more than 99 percent, and is suitable for industrial application. The obtained substituted oxazole compound (I) can be prepared into an oxazole medical Intermediate (IV) through saponification and decarboxylation according to the prior art.
Detailed Description
The present invention is described in detail below with reference to examples, but the present invention is not limited thereto.
In the examples, "%" is a mass percentage unless otherwise specified.
The yields in the examples are all molar yields.
The starting materials and reagents used in the examples are all commercially available products. Raw materials of N-methoxy oxalyl-alpha-alanine methyl ester, N-ethoxy oxalyl glycine ethyl ester and N-ethoxy oxalyl-alpha-phenyl glycine ethyl ester are provided by Shandong Ruihui pharmaceutical industry Co., Ltd, and the GC purity is 99.7%; the raw material N-ethoxy oxalyl-alpha-alanine ethyl ester is provided for new pharmaceutical industry Co.
Performing gas phase detection by using Shimadzu gas chromatograph, wherein the model of the instrument is GC-1020 PLUS; some of the purity was measured by high performance liquid chromatography and is indicated as HPLC.
Example 1: 4-methyl-5-ethoxy-2-ethoxycarbonyloxazole (I)1) Preparation of
Adding 100 g of trichloromethane, 33.3 g (0.1 mol) of triphenyl phosphine dichloride and 21.7 g (0.1 mol) of N-ethoxyoxalyl-alpha-alanine ethyl ester into a 250 ml flask, dropwise adding 20.2 g (0.2 mol) of triethylamine at 20-25 ℃ within 2 hours, reacting at 35-40 ℃ for 1 hour, detecting the reaction of the raw materials, adding 30 g of water, layering, extracting the obtained water layer twice (using 30 g in total) by using the trichloromethane, combining organic phases, distilling the organic phases at normal pressure to recover the trichloromethane, and then distilling under reduced pressure to obtain 18.8 g of 4-methyl-5-ethoxy-2-ethoxycarbonyloxazole, wherein the yield is 94.4%, and the GC purity is 99.9%; the main component of the residue after reduced pressure distillation is triphenylphosphine oxide which can be repeatedly used as a dehydrating agent.
The nuclear magnetic data of the product obtained are as follows:
1H NMR(CDCl3,,ppm):
4.28(q,2H),4.31(q,2H),2.07(s,3H),1.36(t,3H),1.33(t,3H)。
example 2: 4-methyl-5-ethoxy-2-ethoxycarbonyloxazole (I)1) Preparation of
Adding 100 g of toluene, 3.4 g (0.01 mol) of triphenyl phosphine dichloride, 21.7 g (0.1 mol) of N-ethoxyoxalyl-alpha-alanine ethyl ester, 20.8 g (0.206 mol) of triethylamine, dropwise adding a solution of 9.9 g (0.1 mol) of phosgene and 50 g of toluene at the temperature of 25-30 ℃, completing dropwise adding within 2 hours, reacting at the temperature of 65-70 ℃ for 1 hour, detecting that the raw materials are reacted, adding 30 g of water, layering, extracting an obtained water layer twice (using 30 g in total) by using the toluene, combining organic phases, distilling the organic phases at normal pressure to recover the toluene, and then distilling under reduced pressure to obtain 18.9 g of 4-methyl-5-ethoxy-2-ethoxycarbonyl oxazole, wherein the yield is 94.9 percent, and the GC purity is 99.9 percent; the main component of the residue after reduced pressure distillation is triphenylphosphine oxide which can be repeatedly used as a dehydrating agent.
Example 3: 4-methyl-5-ethoxy-2-ethoxycarbonyloxazole (I)1) Preparation of
Adding 100 g of toluene, 27.8 g (0.1 mol) of triphenylphosphine oxide and 21.7 g (0.1 mol) of N-ethoxyoxalyl-alpha-alanine ethyl ester into a 500 ml four-neck flask, dropwise adding a solution of 100 g of toluene and 9.9 g (0.033 mol) of triphosgene into the 500 ml four-neck flask within 2 hours at 20-25 ℃, simultaneously dropwise adding 24.3 g (0.24 mol) of triethylamine, reacting at 45-50 ℃ for 1 hour after double dropwise adding, detecting the reaction completion of raw materials, adding 30 g of water, layering, extracting the obtained water layer twice (using 30 g in total) by using toluene, combining organic phases, distilling the organic phases at normal pressure to recover the toluene, and then distilling under reduced pressure to obtain 19.1 g of 4-methyl-5-ethoxy-2-ethoxycarbonyloxazole with the yield of 96 percent and the purity of GC of 99.9 percent; the main component of the residue after reduced pressure distillation is triphenylphosphine oxide which can be repeatedly used as a dehydrating agent.
Example 4: 4-methyl-5-ethoxy-2-ethoxycarbonyloxazole (I)1) Preparation (with recovered triphenylphosphine oxide)
The residue obtained after recovering 4-methyl-5-ethoxy-2-ethoxycarbonyloxazole by distillation in example 3 was mainly triphenylphosphine oxide and was repeatedly used as a dehydrating agent; dissolving 100 g of toluene, adding the dissolved solution into a 500 ml four-neck flask, adding 21.7 g (0.1 mol) of N-ethoxyoxalyl-alpha-alanine ethyl ester, 24.4 g (0.24 mol) of triethylamine, adding a solution of 100 g of toluene and 9.9 g (0.033 mol) of triphosgene into the 500 ml four-neck flask at 25-30 ℃ within 2 hours, reacting at 45-50 ℃ for 1 hour, detecting the reaction of the raw materials, adding 30 g of water, layering, extracting the obtained water layer twice with toluene (using 30 g in total), combining organic phases, distilling the organic phases at normal pressure to recover toluene, and then distilling under reduced pressure to obtain 19.3 g of 4-methyl-5-ethoxy-2-ethoxycarbonyl oxazole, wherein the yield is 96.9 percent and the GC purity is 99.9 percent; the main component of the residue after reduced pressure distillation is triphenylphosphine oxide which can be repeatedly used as a dehydrating agent.
Example 5: 4-methyl-5-methoxy-2-methoxycarbonyloxazole (I)2) And 4-methyl-5-methoxy oxazole (IV)2) Preparation of
A500 ml four-neck flask is added with 80 g xylene, 27.8 g (0.1 mol) triphenylphosphine oxide, 18.9 g (0.1 mol) N-methoxy oxalyl-alpha-alanine methyl ester, 20.8 g (0.206 mol) triethylamine, a mixed solution of 60 g xylene and 9.9 g (0.1 mol) phosgene is added into the 500 ml four-neck flask at 30-35 ℃ within 2 hours, the mixture reacts at 35-40 ℃ for 1 hour, after the reaction of the raw materials is detected, 30 g water layers are added, the water layers are extracted twice by xylene (30 g is used in total), organic phases are combined, 16.1 g of 4-methyl-5-methoxy-2-methoxycarbonyloxazole is obtained by GC detection, and the yield is 94%.
Adding 20 g of 25% sodium hydroxide aqueous solution into the organic phase, stirring for 30 minutes at room temperature, layering, washing the organic phase for 2 times (30 g of water each time) by using water, and recycling the obtained organic phase as a dehydrating agent; the water layers are combined, 24.7 g of 31 percent hydrochloric acid is added, the pH value is adjusted to be 1.5, the temperature is increased to 60 ℃, the temperature is kept for 30 minutes, the mixture is neutralized to be neutral, reduced pressure distillation is carried out, 10.1 g of 4-methyl-5-methoxy oxazole is obtained, the yield is 89.3 percent by the N-methoxy oxalyl-alpha-alanine methyl ester, and the GC purity is 99.9 percent.
The nuclear magnetic data of the obtained product 4-methyl-5-methoxy oxazole are as follows:
1H NMR(CDCl3,,ppm):
7.33(s,1H),3.89(s,3H),1.99(s,3H)。
example 6: 4-methyl-5-methoxy-2-methoxycarbonyloxazole (I)2) Preparation (with recovered triphenylphosphine oxide)
The residue obtained after recovering 4-methyl-5-ethoxy-2-ethoxycarbonyloxazole by distillation in example 3 was mainly triphenylphosphine oxide and was repeatedly used as a dehydrating agent; dissolving 100 g of toluene, adding the dissolved solution into a 500 ml four-neck flask, adding 18.9 g (0.1 mol) of N-methoxy oxalyl-alpha-alanine methyl ester, 20.8 g (0.206 mol) of triethylamine, adding a solution of 60 g of toluene and 9.9 g (0.1 mol) of phosgene into the 500 ml four-neck flask at the temperature of between 20 and 25 ℃ within 2 hours, reacting at the temperature of between 35 and 40 ℃ for 1 hour, detecting the reaction completion of raw materials, adding 30 g of water layers, extracting the water layers twice by using the toluene (30 g in total), combining organic phases, distilling the organic phases at normal pressure to recover the toluene, and then distilling under reduced pressure to obtain 16.5 g of 4-methyl-5-methoxy-2-methoxycarbonyl oxazole with the yield of 96.4%.
The nuclear magnetic data of the product obtained are as follows:
1H NMR(CDCl3,,ppm):
3.89(s,3H),3.85(s,3H),2.07(s,3H)
example 7: 4-methyl-5-methoxy-2-methoxycarbonyloxazole (I)2) Preparation of
Adding 80 g of cyclohexane, 32 g (0.1 mol) of tris (4-methylphenyl) phosphine oxide, 18.9 g (0.1 mol) of N-methoxyoxalyl-alpha-alanine methyl ester, 28.9 g (0.202 mol) of tri-N-propylamine into a 500 ml four-neck flask, dropwise adding a mixed solution of 11.9 g (0.1 mol) of thionyl chloride and 60 g of cyclohexane at the temperature of 20-25 ℃ within 2 hours, reacting at the temperature of 60-65 ℃ for 1 hour after the dropwise adding is finished, detecting that the raw materials react completely, adding 30 g of water layer, extracting the water layer twice (using 30 g in total) by using cyclohexane, combining organic phases, washing the organic phase once by using 30 g of aqueous solution, layering to obtain an aqueous phase and an organic phase, combining the aqueous phase (using part of water indiscriminately), using the tris (4-methylphenyl) phosphine oxide in the aqueous phase, distilling the obtained organic phase under normal pressure to recover cyclohexane, and then distilling under reduced pressure to obtain 15.6 g of 4-methyl-5-methoxy-2-methoxycarbonyloxazole, the yield was 91.2% and the GC purity was 99.2%.
Example 8: 4-phenyl-5-ethoxy-2-ethoxycarbonyloxazole (I)3) Preparation of
A500 ml four-necked flask was charged with 100 g of toluene, 32 g (0.1 mol) of tris (4-methylphenyl) phosphine oxide, 27.9 g (0.1 mol) of ethyl N-ethoxyoxalyl-. alpha. -phenylglycine, 25.3 g (0.25 mol) of triethylamine, and a solution of 10.1 g (0.034 mol) of triphosgene and 50 g of toluene was added dropwise at 25 to 30 ℃ for 2 hours, followed by reaction at 45 to 50 ℃ for 1 hour, detecting the reaction of the raw materials, adding 30 g of water for layering, extracting a water layer by using toluene (30 g in total), combining organic phases, washing the organic phase once by using 30 g of aqueous solution, layering to obtain a water phase and an organic phase, combining the water phases, distilling the obtained organic phase under reduced pressure to recover the toluene, then carrying out reduced pressure distillation to obtain 22.3 g of 4-phenyl-5-ethoxy-2-ethoxycarbonyl oxazole with the yield of 85.3 percent.
The nuclear magnetic data of the product obtained are as follows:
1H NMR(CDCl3,,ppm):
7.6(d,2H),7.4-7.5(m,3H),4.27(q,2H),4.31(q,2H),1.35(t,3H),1.33(t,3H)
example 9: 5-ethoxy-2-ethoxycarbonyloxazole (I)4) Preparation of
A500 ml four-neck flask is added with 80 g of toluene, 27.8 g (0.1 mol) of triphenylphosphine oxide, 20.3 g (0.1 mol) of ethyl N-ethoxyoxalyl glycinate, 22.2 g (0.22 mol) of triethylamine, a solution of 10.0 g (0.1 mol) of phosgene and 50 g of toluene is dripped between 25 ℃ and 30 ℃ after 2 hours of dripping, the reaction is carried out for 1 hour at 50 ℃ to 55 ℃, 30 g of water layer is added after the detection of the reaction of the raw materials, the water layer is extracted by toluene (30 g in total), organic phases are combined, the organic phase is washed by 30 g of water solution once, water phase and organic phase are obtained by layering, the water phase is combined, the obtained organic phase is decompressed and distilled to recover toluene, then decompressed and distilled to obtain 17.6 g of 5-ethoxy-2-ethoxycarbonyloxazole, the yield is 95.1 percent, and the GC purity is 99.9 percent.
The nuclear magnetic data of the product obtained are as follows:
1H NMR(CDCl3,,ppm):
6.81(s,1H),4.29(q,2H),4.32(q,2H),1.35(t,3H),1.32(t,3H)。
comparative example: 4-methyl-5-ethoxy-2-ethoxycarbonyloxazole (I)1) Preparation of
100 g of trichloromethane, 33.3 g (0.1 mol) of triphenylphosphine dichloride and 21.7 g (0.1 mol) of N-ethoxyoxalyl-alpha-alanine ethyl ester are added into a 250 ml flask, 20.2 g (0.2 mol) of triethylamine is added dropwise at 0-10 ℃ within 2 hours, then the mixture reacts at 0-10 ℃ for 1 hour, 30 g of water is added for layering, the obtained water layer is extracted twice by trichloromethane (30 g in total), organic phases are combined and distilled at normal pressure to recover the trichloromethane, and then the mixture is distilled under reduced pressure to obtain 15.3 g of 4-methyl-5-ethoxy-2-ethoxycarbonyloxazole, wherein the yield is 76.6 percent, and the GC purity is 98.3 percent.
As can be seen from this comparative example, when the reaction temperature is low, the conversion is incomplete and the product yield is low.

Claims (10)

1. An environment-friendly preparation method of a substituted oxazole compound, comprising the steps of:
in a solvent A, under the action of a dehydrating agent and organic amine, a compound shown in a formula II is subjected to cyclization reaction to prepare a substituted oxazole compound (I); the dehydrating agent is a combination of trisubstituted aryl phosphine dichloride, trisubstituted aryl phosphine dichloride and acyl chloride reagent or a combination of trisubstituted aryl phosphine oxide and acyl chloride reagent;
Figure FDA0002020067290000011
wherein in the structural formula of the compound of the formula II, R1Is hydrogen, CnH2n+1A group (1 ≦ n ≦ 10), an aromatic group, or a substituted aromatic group; r2Is hydrogen, CnH2n+1A group (1 ≦ n ≦ 10), an aromatic group, or a substituted aromatic group; r3is-COOR, -CH2COOR or-CH2CH2COOR, wherein R is alkyl.
2. An environmentally friendly process for the preparation of substituted oxazole compounds according to claim 1 comprising one or more of the following conditions:
a. the solvent A is one or a combination of dichloromethane, chloroform, normal hexane, cyclohexane, petroleum ether, normal heptane, xylene, chlorobenzene, benzene, toluene, dimethyl sulfoxide, trichloromethane, trichloroethane or dichloroethane; the mass ratio of the solvent A to the compound shown in the formula II is (0.5-12.0) to 1;
b. the organic amineIs trialkylamine, the alkyl group having the formula CnH2n+1(1 ≦ n ≦ 10); preferably, the alkyl group is a methyl group, an ethyl group, an isopropyl group, an n-propyl group, an isobutyl group or an n-butyl group, and more preferably an ethyl group, an n-propyl group or an n-butyl group; the molar ratio of the organic amine to the compound of the formula II is (1.8-4.0) to 1; preferably, the molar ratio of the organic amine to the compound of the formula II is (2.0-3.0): 1.
3. The environmentally friendly process of claim 1, wherein said trisubstituted aryl phosphine oxide has the structural formula Ar3PO, wherein Ar has a structure shown as formula V below; the structural formula of the tri-substituted aryl phosphine dichloride is Ar3PCl2Wherein Ar has a structure represented by formula V below;
Figure FDA0002020067290000012
wherein in the structural formula shown in the formula V, m is 1, 2, 3, 4 or 5, R4Is hydrogen, CnH2n+1A group (1 ≦ n ≦ 10) or chloro; preferably, R4Is hydrogen.
4. The environmentally friendly process of preparing a substituted oxazole compound of claim 3 wherein the trisubstituted aryl phosphine oxide is triaryl phosphine oxide or tris (4-methylphenyl) phosphine oxide and the trisubstituted aryl phosphine dichloride is triaryl phosphine dichloride.
5. The environmentally friendly process for the preparation of a substituted oxazole compound of claim 1 wherein when the dehydrating agent is a trisubstituted aryl phosphine dichloride, the molar ratio of trisubstituted aryl phosphine dichloride to the compound of formula ii is (0.01-5.0) 1; preferably, the molar ratio of the trisubstituted aryl phosphine dichloride to the compound of formula II is (0.1-1.5): 1; when the dehydrating agent is the combination of the tri-substituted aryl phosphine oxide and the acyl chloride reagent, the molar ratio of the acyl chloride reagent to the compound shown in the formula II is (0.1-2.0):1, and the molar ratio of the tri-substituted aryl phosphine oxide to the compound shown in the formula II is (0.01-5.0): 1; preferably, the molar ratio of the acid chloride reagent to the compound of formula II is (0.3-1):1, and the molar ratio of the trisubstituted aryl phosphine oxide to the compound of formula II is (0.1-1.5): 1; when the dehydrating agent is the combination of the tri-substituted aryl phosphine dichloride and the acyl chloride reagent, the molar ratio of the acyl chloride reagent to the compound shown in the formula II is (0.1-2.0):1, and the molar ratio of the tri-substituted aryl phosphine dichloride to the compound shown in the formula II is (0.01-5.0): 1; preferably, the molar ratio of the acid chloride reagent to the compound of formula II is (0.3-1):1, and the molar ratio of the trisubstituted aryl phosphine dichloride to the compound of formula II is (0.1-1.5): 1.
6. The environmentally friendly process for the preparation of substituted oxazole compounds of claim 1 wherein the acid chloride reagent is sulfuryl chloride, thionyl chloride, oxalyl chloride, carbonyl chloride, phosgene, diphosgene or triphosgene; preferably phosgene or triphosgene.
7. The environmentally friendly process for the preparation of a substituted oxazole compound of claim 1 wherein the acid chloride reagent is added to the system in a dropwise manner.
8. The environmentally friendly process for preparing substituted oxazole compounds as set forth in claim 1 wherein said compound of formula ii is one or a combination of two or more of ethyl N-ethoxyoxalyl- α -alaninate, methyl N-ethoxyoxalyl- α -alaninate, ethyl N-ethoxyoxalyl- α -phenylglycinate or methyl N-ethoxyoxalyl- α -alaninate.
9. The environmentally friendly process for the preparation of substituted oxazole compounds of claim 1 wherein the ring closure reaction temperature is 10 to 80 ℃; preferably, the cyclization reaction temperature is 30-75 ℃.
10. The environmentally friendly process for the preparation of a substituted oxazole compound according to claim 1 wherein the compound of formula ii is cyclized to obtain a reaction solution and the post-treatment of the reaction solution comprises the steps of: adding water into the obtained reaction liquid, layering, extracting the obtained water layer by using a solvent A, and combining organic phases to obtain a water phase and an organic phase; distilling the organic phase at normal pressure to recover the solvent A, and then distilling the organic phase at reduced pressure to obtain a substituted oxazole compound (I); the obtained water phase or the residue of reduced pressure distillation contains trisubstituted aryl phosphine oxide, and the trisubstituted aryl phosphine oxide can be prepared by reacting with acyl chloride reagent to be used as a dehydrating agent or directly recycled to be used as the dehydrating agent; the obtained water phase can be neutralized by sodium hydroxide and distilled to recover organic amine.
CN201910276111.8A 2019-04-08 2019-04-08 Environment-friendly preparation method of substituted oxazole compound Active CN111793038B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910276111.8A CN111793038B (en) 2019-04-08 2019-04-08 Environment-friendly preparation method of substituted oxazole compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910276111.8A CN111793038B (en) 2019-04-08 2019-04-08 Environment-friendly preparation method of substituted oxazole compound

Publications (2)

Publication Number Publication Date
CN111793038A true CN111793038A (en) 2020-10-20
CN111793038B CN111793038B (en) 2022-08-12

Family

ID=72805007

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910276111.8A Active CN111793038B (en) 2019-04-08 2019-04-08 Environment-friendly preparation method of substituted oxazole compound

Country Status (1)

Country Link
CN (1) CN111793038B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111153869A (en) * 2020-01-19 2020-05-15 浙江新和成股份有限公司 Method for preparing oxazole compound
CN113336717A (en) * 2021-06-01 2021-09-03 江西天新药业股份有限公司 Process for preparing oxazole carboxylic acid esters
WO2022077196A1 (en) * 2020-10-12 2022-04-21 新发药业有限公司 Environmentally friendly preparation method for substituted oxazole compound
CN114644577A (en) * 2020-12-18 2022-06-21 新发药业有限公司 Environment-friendly preparation method of substituted isonitrile compound

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN86101512A (en) * 1986-07-07 1988-01-13 国家医药管理局上海医药工业研究院 The synthesis technique of vitamin B6 intermediate 4-methyl-5-alkoxy-oxazole
WO2005019212A1 (en) * 2003-08-20 2005-03-03 Eli Lilly And Company Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
CN102060801A (en) * 2010-12-31 2011-05-18 浙江工业大学 Method for synthesizing 5-alkoxy-substituted oxazole compound
CN102321043A (en) * 2011-07-12 2012-01-18 湖北惠生药业有限公司 Preparation method for 4-methyl-5-ethyoxyl-oxazole
CN103435568A (en) * 2013-08-30 2013-12-11 大丰海嘉诺药业有限公司 Preparation method of 4-methyl-5-ethoxy oxazole acid ethyl
CN103880766A (en) * 2014-03-31 2014-06-25 新发药业有限公司 Simple and convenient preparation method of 4-methyl-5-alkoxy oxazole
CN104321314A (en) * 2012-03-29 2015-01-28 盐野义制药株式会社 N-phenyl-n'-phenylsulfonylpiperazine derivative and method for producing intermediate for same
CN105985297A (en) * 2015-01-30 2016-10-05 湖北得正医药科技有限公司 Synthesis technology of vitamin B6 intermediate 4-methyl-5-ethyoxyl-2-oxazole acid ethyl
CN109305946A (en) * 2018-11-29 2019-02-05 湖北惠生药业有限公司 A kind of synthetic method of 4- methyl -5- ethyoxyl oxazole

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN86101512A (en) * 1986-07-07 1988-01-13 国家医药管理局上海医药工业研究院 The synthesis technique of vitamin B6 intermediate 4-methyl-5-alkoxy-oxazole
WO2005019212A1 (en) * 2003-08-20 2005-03-03 Eli Lilly And Company Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
CN102060801A (en) * 2010-12-31 2011-05-18 浙江工业大学 Method for synthesizing 5-alkoxy-substituted oxazole compound
CN102321043A (en) * 2011-07-12 2012-01-18 湖北惠生药业有限公司 Preparation method for 4-methyl-5-ethyoxyl-oxazole
CN104321314A (en) * 2012-03-29 2015-01-28 盐野义制药株式会社 N-phenyl-n'-phenylsulfonylpiperazine derivative and method for producing intermediate for same
CN103435568A (en) * 2013-08-30 2013-12-11 大丰海嘉诺药业有限公司 Preparation method of 4-methyl-5-ethoxy oxazole acid ethyl
CN103880766A (en) * 2014-03-31 2014-06-25 新发药业有限公司 Simple and convenient preparation method of 4-methyl-5-alkoxy oxazole
CN105985297A (en) * 2015-01-30 2016-10-05 湖北得正医药科技有限公司 Synthesis technology of vitamin B6 intermediate 4-methyl-5-ethyoxyl-2-oxazole acid ethyl
CN109305946A (en) * 2018-11-29 2019-02-05 湖北惠生药业有限公司 A kind of synthetic method of 4- methyl -5- ethyoxyl oxazole

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YE ZOU,ET AL.: "Improved "Oxazole" Method for the Practical and Efficient Preparation of Pyridoxine Hydrochloride (Vitamin B6)", 《ORG. PROCESS RES. DEV》 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111153869A (en) * 2020-01-19 2020-05-15 浙江新和成股份有限公司 Method for preparing oxazole compound
CN111153869B (en) * 2020-01-19 2021-06-01 浙江新和成股份有限公司 Method for preparing oxazole compound
WO2021143181A1 (en) * 2020-01-19 2021-07-22 上虞新和成生物化工有限公司 Method for preparing oxazole compound
WO2022077196A1 (en) * 2020-10-12 2022-04-21 新发药业有限公司 Environmentally friendly preparation method for substituted oxazole compound
CN114644577A (en) * 2020-12-18 2022-06-21 新发药业有限公司 Environment-friendly preparation method of substituted isonitrile compound
WO2022126947A1 (en) * 2020-12-18 2022-06-23 新发药业有限公司 Environmentally friendly preparation method for substituted isonitrile compound
CN114644577B (en) * 2020-12-18 2023-06-27 新发药业有限公司 Environment-friendly preparation method of substituted isonitrile compound
CN113336717A (en) * 2021-06-01 2021-09-03 江西天新药业股份有限公司 Process for preparing oxazole carboxylic acid esters
CN113336717B (en) * 2021-06-01 2024-04-05 江西天新药业股份有限公司 Process for preparing oxazolecarboxylic acid esters

Also Published As

Publication number Publication date
CN111793038B (en) 2022-08-12

Similar Documents

Publication Publication Date Title
CN111793038B (en) Environment-friendly preparation method of substituted oxazole compound
Jackson et al. Preparation of enantiomerically pure protected 4-oxo. alpha.-amino acids and 3-aryl. alpha.-amino acids from serine
del Villar et al. Nitrogen ylide-mediated cyclopropanation of lactams and lactones
RU2730006C1 (en) Method of producing 5r-[(benzyloxy)amino]piperidine-2s-carboxylic acid or derivative thereof
JP2005511782A (en) Process for the preparation of 2-halogenacyl-3-amino-acrylic acid derivatives
US10662190B2 (en) Process for preparing 5R-[(benzyloxy) amino] piperidine-2S-carboxylate and oxalates thereof
CN107674044B (en) Method for synthesizing carbamate by using carbon dioxide, amine and aryl diazo acetate
CN112174907B (en) Environment-friendly preparation method of substituted oxazole compound
Rawat et al. Synthesis of the anti-influenza agent (−)-oseltamivir free base and (−)-methyl 3-epi-shikimate
Reddy et al. An efficient catalyst-free one-pot synthesis of primary amides from the aldehydes of the Baylis–Hillman reaction
WO2015189862A1 (en) Chiral amines, a process for preparation and use thereof
JP4793976B2 (en) Optically active hydrazine compound and method for producing optically active amine compound
CN106966940B (en) A kind of preparation method of Sitagliptin phosphate intermediate N arylmethyl -2S- cyano methyl acridine
CA2560964C (en) Synthesis of pyrrole-2-carbonitriles
Ahadi et al. Diastereoselective synthesis of polysubstituted cyclopentanols and cyclopentenes containing stereogenic centers via domino Michael/cyclization reaction
CN114644577B (en) Environment-friendly preparation method of substituted isonitrile compound
CN113912535B (en) Preparation method of 6-chloro-4-trifluoromethyl-3-cyanopyridine
CA3141865A1 (en) An environment-friendly preparation method of a substituted oxazole compound
JP4255296B2 (en) Method for producing cyclic fluorinated alcohol
He et al. One-pot three-component reaction of fluoroalkanesulfonyl azide, vinyl ether and aldehyde: the formation of polysubstituted fluorinated oxazolidines
Ji A FACILE METHOD FOR THE SYNTHESIS OF THIAZOLIUM SALTS USING P2S5-PY2 COMPLEX AND THEIR APPLICATION IN INTERMOLECULAR STETTER REACTIONS
Gravel et al. A Facile Method for the Synthesis of Thiazolium Salts Using P2S5-Py2 Complex and Their Application in Intermolecular Stetter Reactions
TW202302550A (en) Method for preparing alkyl 4-oxotetrahydrofuran-2-carboxylate
JP5107286B2 (en) Method using phosphonimidate as a nucleophile
CN114920669A (en) Synthesis method of N-methyl-N-benzyloxycarbonyl-L-aspartic acid (4-tert-butyl ester) dicyclohexylamine salt

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
PE01 Entry into force of the registration of the contract for pledge of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: An environmentally friendly preparation method for substituted oxazole compounds

Effective date of registration: 20231130

Granted publication date: 20220812

Pledgee: Dongying Branch of China CITIC Bank Co.,Ltd.

Pledgor: Xinfa pharmaceutical Co.,Ltd.

Registration number: Y2023980068537